Synthesis and in vitro reactivity of 3-carbamoyl-2-phenylpropionaldehyde and 2-phenylpropenal: putative reactive metabolites of felbamate

Chemical Research in Toxicology
C D ThompsonT L Macdonald

Abstract

We propose that 3-carbamoyl-2-phenylpropionaldehyde is an intermediate in the metabolism of felbamate, an anti-epileptic drug with a unique profile of the therapeutic activity, and undergoes a cascade of chemical reactions responsible for the toxic properties of the parent drug. To test this hypothesis, we have synthesized 3-carbamoyl-2-phenylpropionaldehyde and evaluated its in vitro reactivity. This molecule was found to be highly unstable at physiological pH (t1/2 < or = 30 s) and to undergo facile elimination to 2-phenylpropenal, an alpha, beta-unsaturated aldehyde commonly termed atropaldehyde. However, the predominant reaction pathway for 3-carbamoyl-2-phenylpropionaldehyde was reversible cyclization to generate 4-hydroxy-5-phenyltetrahydro-1,3-oxazin-2-one, a urethane that has a considerably longer half-life at physiological pH (t1/2 > or = 5 h) and may serve as a stable reservoir of the reactive aldehyde both in vitro and in vivo. Atropaldehyde is a potent electrophile and was found to exhibit cytotoxicity to cultured fibroblasts (50% growth inhibition (GI50) = 4.1 +/- 1.1 microM) comparable to the known unsaturated aldehyde toxins, 4-hydroxy-2-nonenal and acrolein. 3-Carbamoyl-2-phenylpropionaldehyde also exhibited sig...Continue Reading

Citations

Jan 3, 2007·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Bryan A RoeckleinJames Stables
Oct 26, 2002·Chemico-biological Interactions·Christine M DieckhausTimothy L Macdonald
Jun 6, 1998·The Journal of Biological Chemistry·S SrivastavaA Bhatnagar
Jul 15, 2000·Clinical Neuropharmacology·B F Bourgeois
Mar 28, 2007·Epilepsia·Gaetano ZaccaraEmilio Perucca
Oct 20, 2006·Clinical Pharmacokinetics·Svein I Johannessen, Torbjörn Tomson
Dec 8, 2004·Drug Discovery Today·Alaa-Eldin F NassarCaroline Clarimont
Nov 28, 2006·Expert Opinion on Drug Metabolism & Toxicology·John Cl Erve
Nov 28, 2006·Expert Opinion on Drug Metabolism & Toxicology·Margherita Strolin BenedettiEugène Baltes
May 31, 2006·Expert Opinion on Investigational Drugs·Meir Bialer
Jul 2, 2005·Critical Reviews in Toxicology·Jennie L WalgrenDavid C Thompson
May 6, 2010·Drug Metabolism Reviews·Federica VacondioBernard Testa
Oct 26, 2002·Chemico-biological Interactions·Izet M KapetanovicHarvey J Kupferberg
Feb 1, 2006·Environmental Toxicology and Pharmacology·Julia Ip, Jack P Uetrecht
Sep 19, 2002·Seizure : the Journal of the British Epilepsy Association·Andrey M MazaratiClaude G Wasterlain
Mar 18, 2008·Acta Neurologica Scandinavica·E Björnsson
May 27, 2003·Therapeutic Drug Monitoring·Svein I JohannessenPhilip N Patsalos
Aug 29, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·G S J MannensW Meuldermans
Jun 19, 2012·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Renzo GuerriniAnna Rosati
Nov 26, 2020·Therapeutic Drug Monitoring·Smita PattanaikJasmina Ahluwalia

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.